
Genomic Health nets $54mm in IPO
Executive Summary
In its initial public offering, cancer diagnostics company Genomic Health netted $54mm through the sale of about 5mm shares priced at $12 each.
Deal Industry
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Financing
- IPO
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com